Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teun Bousema

Showing results (311-320 of 340) with videos related to

Pageof 34
Sort By:
Nature Communications|October 28, 2017
Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensityBronner P Gonçalves, Melissa C Kapulu, Patrick Sawa, et al.
Plos One|September 1, 2012
Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriersTeun Bousema, Rhoel R Dinglasan, Isabelle Morlais, et al.
Nature Communications|June 14, 2014
A barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strainsMark D Preston, Susana Campino, Samuel A Assefa, et al.
Frontiers in Cellular and Infection Microbiology|February 2, 2023
Naturally acquired antibodies to gametocyte antigens are associated with reduced transmission of <i>Plasmodium vivax</i> gametocytes to <i>Anopheles arabiensis</i> mosquitoesSurafel K Tebeje, Wakweya Chali, Elifaged Hailemeskel, et al.
Frontiers in Genetics|April 26, 2021
G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical TrialsNuno Sepúlveda, Lynn Grignard, Jonathan Curry, et al.
Elife|February 28, 2018
A randomized feasibility trial comparing four antimalarial drug regimens to induce <i>Plasmodium falciparum</i> gametocytemia in the controlled human malaria infection modelIsaie J Reuling, Lisanne A van de Schans, Luc E Coffeng, et al.
The Lancet. Microbe|July 28, 2024
Effect of weekly fever-screening and treatment and monthly RDT testing and treatment on the infectious reservoir of malaria parasites in Burkina Faso: a cluster-randomised trialKatharine A Collins, Alphonse Ouedraogo, Wamdaogo Moussa Guelbeogo, et al.
Immunity|October 10, 2025
Cryo-EM structure of endogenous Pfs230:Pfs48/45 complex with six antibodies reveals mechanisms of malaria transmission-blocking activityEzra T Bekkering, Randy Yoo, Sophia Hailemariam, et al.
Immunity|February 15, 2023
Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230Danton Ivanochko, Amanda Fabra-García, Karina Teelen, et al.
The Lancet. Infectious Diseases|August 13, 2022
Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adultsSaskia C van der Boor, Merel J Smit, Stijn W van Beek, et al.
Pageof 34

Showing results (311-320 of 340) with videos related to

Sort By:
Pageof 34
Nature Communications|October 28, 2017
Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensityBronner P Gonçalves, Melissa C Kapulu, Patrick Sawa, et al.
Plos One|September 1, 2012
Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriersTeun Bousema, Rhoel R Dinglasan, Isabelle Morlais, et al.
Nature Communications|June 14, 2014
A barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strainsMark D Preston, Susana Campino, Samuel A Assefa, et al.
Frontiers in Cellular and Infection Microbiology|February 2, 2023
Naturally acquired antibodies to gametocyte antigens are associated with reduced transmission of <i>Plasmodium vivax</i> gametocytes to <i>Anopheles arabiensis</i> mosquitoesSurafel K Tebeje, Wakweya Chali, Elifaged Hailemeskel, et al.
Frontiers in Genetics|April 26, 2021
G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical TrialsNuno Sepúlveda, Lynn Grignard, Jonathan Curry, et al.
Elife|February 28, 2018
A randomized feasibility trial comparing four antimalarial drug regimens to induce <i>Plasmodium falciparum</i> gametocytemia in the controlled human malaria infection modelIsaie J Reuling, Lisanne A van de Schans, Luc E Coffeng, et al.
The Lancet. Microbe|July 28, 2024
Effect of weekly fever-screening and treatment and monthly RDT testing and treatment on the infectious reservoir of malaria parasites in Burkina Faso: a cluster-randomised trialKatharine A Collins, Alphonse Ouedraogo, Wamdaogo Moussa Guelbeogo, et al.
Immunity|October 10, 2025
Cryo-EM structure of endogenous Pfs230:Pfs48/45 complex with six antibodies reveals mechanisms of malaria transmission-blocking activityEzra T Bekkering, Randy Yoo, Sophia Hailemariam, et al.
Immunity|February 15, 2023
Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230Danton Ivanochko, Amanda Fabra-García, Karina Teelen, et al.
The Lancet. Infectious Diseases|August 13, 2022
Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adultsSaskia C van der Boor, Merel J Smit, Stijn W van Beek, et al.
Pageof 34